Referanslar

1. Odland gF. Structure of the skin. In: goldsmith LA, editor. Physiology, biochemistry and molecular biology of the skin. 2 nd ed. New York: Oxford University Press; 1991. p. 3-62.
2. Kanitakis j. Anatomy, histology and immunohistochemistry of normal human skin. Eur j Dermatol. 2002;12(4):390-9.
3. Murphy g. F. Histology of the skin. In: Elder D, Elenitsas R, jaworskyC, johnson B, eds. Lever's histopathology of the skin. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 1997. p. 5-45.
4. Hsu YC, Li L, Fuchs E. Emerging interactions between skin stem cells and their niches. Nat Med. 2014;20(8):847-56. [Crossref]  [PubMed]  [PMC]
5. Koster MI. Making an epidermis. Ann N Y Acad Sci. 2009;1170:7-10. [Crossref]  [PubMed]  [PMC]
6. Lizuka H. Epidermal turnover time. j Dermatol Sci. 1994;8(3):215-7. [Crossref]  [PubMed]
7. Chu DH. Overview of biology, development, and structure of skin. In: K Wolff, LA goldsmith, S I Katz, BA gilchrest, AS Paller, Dj Leffell, eds, Fitzpatrick's dermatology in general medicine. 7th ed. New York: Mcgraw-Hill; 2008. p 57-73.
8. Yagi M, Yonei Y. glycative stress and antiaging:7. glycative stress and skin aging. glycative Stress Research. 2018;5(1):050-4.
9. Gayraud B, Hopfner B, jassim A, Aumailley M, Bruckner- Tuderman L. Characterization of a 50- kDa component of epithelial basement membranes using gDA-j/F3 monoclonal antibody. jBiol Chem.1997;272(14):9531-8. [Crossref]  [PubMed]
10. Stepp MA, Spurr-Michaud S, Tisdale A, Elwell j, gipson I K. Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci USA. 1990;87(22): 8970-4. [Crossref]  [PubMed]  [PMC]
11. green EM, Mansfield jC, Bell jS, Winlove CP. The structure and micromechanics of elastic tissue. Interface Focus. 2014;4(2):20130058. [Crossref]  [PubMed]  [PMC]
12. Kolarsick Paul Aj, Kolarsick MA, goodwin C. Anatomy and Physiology of the Skin. journal of the Dermatology Nurses' Association. 2011; 3(4):203-13. [Crossref]
13. Boulant, j. A. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis. 2000;31(5);157-61. [Crossref]  [PubMed]
14. Woodley, D.T. Distinct Fibroblasts in the Papillary and Reticular Dermis: Implications for Wound Healing. Dermatol Clin. 2017;35(1): 95- 100. [Crossref]  [PubMed]
15. Chu D H. Overview of biology, development, and structure of skin. In: goldsmith LA, Katz SI, gilchrest BA, Paller AS, Leffell Dj, eds. Fitzpatrick's dermatology in general medicine. 7th ed. New York: Mcgraw-Hill; 2001. p. 57-73.
16. james WD, Berger Tg, Elston DM. Andrews's diseases of the skin: Clinical dermatology.10th ed. Philadelphia: Elsevier Saunders; 2006.
17. Menon gK, Cleary gW, Lane ME. The structure and function of the stratum corneum. Int j Pharm. 2012;435(1):3-9. [Crossref]  [PubMed]
18. Niyonsaba F, Kiatsurayanon C, Chieosilapatham P, Ogawa H. Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases. Exp Dermatol. 2017; 26(11):989-98. [Crossref]  [PubMed]
19. Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol. Physiol. 2006;19(6): 296-302. [Crossref]  [PubMed]
20. Kashem SW, Haniffa M, Kaplan DH. AntigenPresenting Cells in the Skin. Annu Rev Immunol. 2017;35:469-99. [Crossref]  [PubMed]
21. Sumpter TL, Balmert SC, Kaplan DH. Cutaneous immune responses mediated by dendritic cells and mast cells. jCI Insight. 2019; 4(1):123947 [Crossref]  [PubMed]  [PMC]
22. Suwanpradid j, Holcomb zE, MacLeod AS. Emerging Skin T-Cell Functions in Response to Environmental Insults. j Invest Dermatol. 2017;137(2):288-94. [Crossref]  [PubMed]  [PMC]
23. Nguyen AV, Soulika AM. The Dynamics of the Skin's Immune System. Int j Mol Sci. 2019; 20(8):1811. [Crossref]  [PubMed]  [PMC]
24. Deckers j, Hammad H, Hoste E. Langerhans Cells: Sensing the Environment in Health and Disease. Front. Immunol. 2018;9:93. [Crossref]  [PubMed]  [PMC]
25. Atmatzidis DH, Lambert WC, Lambert MW. Langerhans cells: exciting developments in health and disease. j Eur Acad Dermatol Venereol. 2017;31(11):1817-24. [Crossref]  [PubMed]
26. Kaplan DH. Ontogeny and function of murine epidermal Langerhans cells. Nat Immunol. 2017;18(10):1069-75. [Crossref]  [PubMed]  [PMC]
27. Strandt H, Pinheiro DF, Kaplan DH, Wirth D, gratz IK, Hammerl P, et al.Neoantigen Expression in Steady-State Langerhans Cells Induces CTLTolerance. j Immunol. 2017;199 (5):1626-34. [Crossref]  [PubMed]  [PMC]
28. Novak N, Koch S, Allam jP, Bieber T. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis. j Allergy Clin Immunol. 2010;125(1):50-9. [Crossref]  [PubMed]
29. Yu CF, Peng WM, Oldenburg j, Hoch j, Bieber T, Limmer A, et al. Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation. j Immunol. 2010;184(3):1159-67. [Crossref]  [PubMed]
30. Yu CF, Peng WM, Schlee M, Barchet W, EisHübinger AM, Kolanus W, et al. SOCS1 and SOCS3 Target IRF7 Degradation To Suppress TLR7-Mediated Type I IFN Production of Human Plasmacytoid Dendritic Cells. j Immunol. 2018;200(12):4024-35. [Crossref]  [PubMed]
31. Sheng j, Ruedl C, Karjalainen K. Most TissueResident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells. Immunity.2015;43(2):382-93. [Crossref]  [PubMed]
32. TamoutounourS, guilliams M, Montanana Sanchis F, Liu H, Terhorst D, Malosse C,et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity. 2013;39(5):925-38. [Crossref]  [PubMed]
33. Eichmuller S, van derVeen C, Moll I, Hermes B, Hofmann U, Muller-Rover S, Paus R. Clusters of perifollicular macrophages in normal murine skin: Physiological degeneration of selected hair follicles by programmed organ deletion. j. Histochem. Cytochem. 1998;46 (3);361-70. [Crossref]  [PubMed]
34. Nahrendorf M, Swirski F.K. Abandoning M1/M2 for a Network Model of Macrophage Function. Circ Res. 2016;119(3):414-7. [Crossref]  [PubMed]  [PMC]
35. janssens AS, Heide R, den Hollander jC, Mulder Pg, Tank B, Oranje AP. Mast cell distribution in normal adult skin. j Clin Pathol. 2005;58(3):285-9. [Crossref]  [PubMed]  [PMC]
36. Bradding P, Saito H. Biology of Mast Cells and Their Mediators. In: Adkinson F, Bochner B, Burks A, Holgate S, Lemanske R, O'Hehir R, eds. Middleton's Allergy: Principles and Practice. 8st ed.Philadelphia: Elsevier Saunders; 2013. p. 228-51. [Crossref]
37. Mukai K, Tsai M, Saito H, galli Sj. Mast cells as sources of cytokines,chemokines, and growth factors. Immunol Rev. 2018;282(1): 121-50. [Crossref]  [PubMed]  [PMC]
38. Subramanian H, gupta K, Ali H. Roles of Mas-related g protein-coupled receptor X2 on mast cell-mediated host defense,pseudoallergic drug reactions,and chronic inflammatorydiseases. j Allergy Clin Immunol. 2016;138(3): 700-10. [Crossref]  [PubMed]  [PMC]
39. Fujisawa D, Kashiwakura j, KitaH, Kikukawa Y, Fujitani Y, Sasaki-Sakamoto T, et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. j Allergy Clin Immunol. 2014;134(3):622-33. [Crossref]  [PubMed]
40. Yu YR, O'Koren Eg, Hotten DF, Kan Mj, Kopin D, Nelson ER, et al. A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues. PLoS One. 2016; 11(3): e0150606. [Crossref]  [PubMed]  [PMC]
41. Long H, zhang g, Wang L, Lu Q. Eosinophilic Skin Diseases: A Comprehensive Review. Clin Rev Allergy Immunol. 2016;50(2):189-213. [Crossref]  [PubMed]
42. Spencer LA, Szela CT, Perez SA, Kirchhoer CL, Neves jS, Radke AL, Weller PF. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. j Leukoc Biol. 2009;85(1):117-23. [Crossref]  [PubMed]  [PMC]
43. Luna-gomes T, Magalhaes Kg, MesquitaSantos FP, Bakker-Abreu I, Samico RF, Molinaro R, Calheiros AS, et al. Eosinophils as a novel cell source of prostaglandinD2: Autocrine role in allergic inflammation. j Immunol. 2011;187(12):6518-26. [Crossref]  [PubMed]  [PMC]
44. Ueki S, Melo RC, ghiran I, Spencer LA, Dvorak AM, Weller PF. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood. 2013;121(11):2074-83. [Crossref]  [PubMed]  [PMC]
45. Ofuji, S. Eosinophilic pustular folliculitis. Dermatologica. 1987;174(2):53-6. [Crossref]  [PubMed]
46. F. Ferrier M.C, janin-Mercier A, Souteyrand P, Bourges M, Hermier C. Eosinophilic cellulitis (Wells'syndrome): Ultrastructural study of a case with circulating immune complexes. Dermatologica. 1988;176(6):299-304. [Crossref]  [PubMed]
47. Elbe A, Foster CA, Stingl g. T-cell receptor alpha beta and gamma delta T cells in rat and human skin-are they equivalent? Semin Immunol. 1996;8(6):341-9. [Crossref]  [PubMed]
48. Mackay LK, Rahimpour A, Ma jz, Collins N, Stock AT, Hafon ML, et al. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 2013; 14(12):1294-301. [Crossref]  [PubMed]
49. Gomez de Aguero M, Vocanson M, HaciniRachinel F, Taillardet M, Sparwasser T, Kissenpfennig A, et al. Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. j Clin Invest. 2012;122(5):1700-11. [Crossref]  [PubMed]  [PMC]
50. Muraro A, Lemanske RF jr, Hellings PW, Akdis CA, Bieber T, Casale TB, et al. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitisPRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. j Allergy Clin Immunol. 2016;137 (5):1347-58. [Crossref]  [PubMed]
51. Werfel T, Allam jP, Biedermann T, Eyerich K, gilles S, guttman-Yassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. j AllergyClin Immunol. 2016;138(2):336-49. [Crossref]  [PubMed]
52. Breiteneder H, Diamant z, Eiwegger T, Fokkens Wj, Traidl-Hoffmann C, Nadeau K, et al. Future trends in mechanisms and patient care in allergic diseases. Allergy. 2019;74(12): 2293-311. [Crossref]  [PubMed]  [PMC]
53. Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon HU, graeve T, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. j Clin Invest. 2000;106(1):25-35. [Crossref]  [PubMed]  [PMC]
54. Pichler Wj. Immune pathomechanism and classification of drug hypersensitivity. Allergy.. 2019;74(8):1457-71. [Crossref]  [PubMed]
55. Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg gF, et al. TSLP elicits IL33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med. 2013;5(170):170ra16. [Crossref]
56. Salimi M, Barlow jL, Saunders SP, Xue L, gutowska-Owsiak D, Wang X, et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. j Exp Med. 2013; 210(13):2939-50. [Crossref]  [PubMed]  [PMC]
57. Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yoshimoto T, et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci USA. 2013;110(34):13921-26. [Crossref]  [PubMed]  [PMC]
58. Kim BS, Wang K, Siracusa MC, Saenz SA, Brestoff jR, Monticelli LA, et al. Basophils promote innate lymphoid cell responses in inflamed skin. j Immunol. 2014;193(7):3717- 25. [Crossref]  [PubMed]  [PMC]
59. Nihal M, Mikkola D, Wood gS. Detection of clonally restricted immunoglobulin heavy chain gene rearrangements in normal and lesional skin: Analysis of the B cell component of the skin-associated lymphoid tissue and implications for the molecular diagnosis of cutaneous B cell lymphomas. j Mol Diagn. 2000; 2(1):5-10. 60. [Crossref]  [PubMed]
60. Egbuniwe IU, Karagiannis SN, Nestle FO, Lacy KE. Revisiting the role of B cells in skin immune surveillance. Trends Immunol. 2015; 36(2):102-11. [Crossref]  [PubMed]
61. Postigo AA, Marazuela M, Sanchez-Madrid F, de Landazuri M.O. B lymphocyte binding to Eand P-selectins is mediated through the de novo expression of carbohydrates on in vitro and in vivo activated human B cells. j Clin Investig. 1994;94(4):1585-96. [Crossref]  [PubMed]  [PMC]
62. Simon D, Hösli S, Kostylina g, Yawalkar N, Simon HU. Anti-CD20 (rituximab) treatment improves atopic eczema. j. Allergy Clin. Immunol. 2008;121(1):122-8. [Crossref]  [PubMed]
63. Geiger B, Wenzel j, Hantschke M, Haase I, Stander S, von Stebut E. Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells. Br j Dermatol. 2010;162(4):870-4. [Crossref]  [PubMed]
64. Lafyatis R, Kissin E, York M, Farina g, Viger K, Fritzler Mj, et al. B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum. 2009;60(2): 578-83. [Crossref]  [PubMed]  [PMC]